Healthcare costs in India are rising at approximately 14% annually in 2026 — the highest rate in Asia and nearly triple the general rate of inflation — placing private hospitalisation increasingly beyond the reach of middle-class households and generating a gap between official health inflation statistics and the actual cost experience of patients, according to analysis by Onsurity cited in the research documents.
The official health inflation figure from late 2025 stood at approximately 3.43%, according to the research documents, but analysts describe this as a “massive disconnect” from patient reality because the official index primarily tracks basic generic medicines rather than the specialised surgeries, diagnostics, and room rents that constitute the bulk of hospitalisation costs for non-communicable disease treatment.
The Drivers
The primary cost drivers identified in the research documents are: the post-pandemic explosion in Non-Communicable Diseases including heart disease, cancer, and diabetes, which require long-term and often expensive management; the adoption of AI-driven diagnostics and robotic surgeries, cited by over 74% of insurers as a primary cost contributor; and a structural shortage of public hospital beds, with India having only 1.3 hospital beds per 1,000 people, forcing patients into private hospital chains where Average Revenue Per Occupied Bed has risen by 10 to 16%, according to the research documents.
The $23.8 billion medical tourism market is also identified as a cost factor, as top private hospital chains apply premium pricing tiers originally designed for international patients to local patients as well, according to the research documents.
Insurance premiums for senior citizens have risen by 30 to 50% between age brackets, according to the research documents. In response, the Insurance Regulatory and Development Authority of India has implemented a 10% annual cap on premium increases for senior citizens, and GST on health insurance has been reduced from 18% to 5% in early 2026, with a 0% rate applied to younger policyholders, according to the research documents. Whether these measures are sufficient to offset a 14% underlying cost inflation rate is, according to the research documents, a matter of active policy debate.